Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer
- PMID: 26577654
- PMCID: PMC5964905
- DOI: 10.1093/jnci/djv329
Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer
Abstract
Background: Several lifestyle factors have been associated with risk of lethal prostate cancer, but little is known about their combined effect. Our objective was to develop and apply a lifestyle score for prevention of lethal prostate cancer.
Methods: We developed a lifestyle score among 42 701 men in the Health Professionals Follow-up Study (HPFS) followed from 1986 to 2010 and applied it among 20 324 men in the Physicians' Health Study (PHS) followed from 1982 to 2010. One point was given for each of: not currently smoking or quit 10 or more years ago, body mass index under 30 kg/m(2), high vigorous physical activity, high intake of tomatoes and fatty fish, and low intake of processed meat. Diet-only scores (range = 0-3) and total scores (range = 0-6) were calculated. We used multivariable Cox proportional hazards regression to estimate the risk of lethal prostate cancer, adjusting for potential risk factors of lethal prostate cancer. All statistical tests were two-sided.
Results: We observed 576 lethal prostate cancer events in HPFS and 337 in PHS. Men with 5-6 vs 0-1 points had a 68% decreased risk of lethal prostate cancer (hazard ratio [HR] = 0.32, 95% confidence interval [CI] = 0.19 to 0.52) in HPFS and a non-statistically significant 38% decreased risk (HR = 0.62, 95% CI = 0.30 to 1.26) in PHS. For dietary factors only, men with 3 vs 0 points had a 46% decreased risk (HR = 0.54, 95% CI = 0.30 to 0.96) in the HPFS and a non-statistically significant 30% decreased risk (HR = 0.70, 95% CI = 0.40 to 1.23) in PHS.
Conclusions: Adhering to a healthy lifestyle, defined by not smoking, normal body weight, high physical activity, and a healthy diet, may lower risk of lethal prostate cancer.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
References
-
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr Accessed on August 7, 2015.
-
- Cancer Facts & Figures 2014. American Cancer Society; 2014.
-
- Nambiar D, Singh RP. Advances in prostate cancer chemoprevention: a translational perspective. Nutrition and Cancer. 2013;65(Suppl 1):12–25. - PubMed
-
- Klein EA, Thompson IM. Chemoprevention of prostate cancer: an updated view. World J Urology. 2012;30(2):189–194. - PubMed
Publication types
MeSH terms
Grants and funding
- CA167552/CA/NCI NIH HHS/United States
- CA133891/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- CA131945/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- R01 CA131945/CA/NCI NIH HHS/United States
- CA097193/CA/NCI NIH HHS/United States
- CA09001/CA/NCI NIH HHS/United States
- R01 CA133891/CA/NCI NIH HHS/United States
- R01 HL026490/HL/NHLBI NIH HHS/United States
- CA141298/CA/NCI NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
- T32 CA009001/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- R01 CA040360/CA/NCI NIH HHS/United States
- CA055075/CA/NCI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- CA40360/CA/NCI NIH HHS/United States
- R01 CA034944/CA/NCI NIH HHS/United States
- R01 CA141298/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
